Azura Ophthalmics announced it has received positive feedback from a pre-New Drug Application (NDA) meeting with the US Food ...

Cogent Biosciences (COGT) shares have surged after pivotal bezuclastinib data in imatinib-resistant aGIST. Read the latest ...

Abivax receives a "Strong Buy" rating, driven by positive phase 3 ABTECT induction data for obefazimod in moderate-to-severe ...

BJP-led NDA secured 50 of the 101 wards in Thiruvananthapuram Corporation, the LDF bagged 29, while the UDF tally was 19. UDF ...

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders ...

Revive Therapeutics (RVVTF) announced an update on its ongoing research study evaluating Bucillamine as a potential treatment for nerve agent ...

Explore the complexities of Macaulay's legacy and the challenge of preserving educational integrity amidst ideological ...

Mark Carney was elected on a promise to “move at unimaginable speeds,” but since the election, all we’ve seen from the ...

Roivant enters new phase of corporate journey with 3+ launches, 4+ NDA/BLA filings, 8+ pivotal and 3+ proof-of-concept study readouts expected over the next three yearsHighlighting clinical execution, ...

The US Food and Drug Administration (FDA) has granted Neurizon Therapeutics an early Christmas present by completing its ...

An announcement from Revive Therapeutics ( ($TSE:RVV) ) is now available. Revive Therapeutics has announced an update on its research study ...

B&K Securities this week initiated coverage on Hindustan Aeronautics with a 'Buy' and a target price of  Rs 5,610. India’s defence-aerospace landscape is at an inflection point, it said.